National Health Investors financials
$66.66−0.27%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $121.3M | $115.1M | $101.0M | $83.4M | $90.7M | $89.3M | $79.8M | $77.1M | $85.0M | $81.5M | $79.5M | $80.1M |
| Gross profit | $121.3M | $115.1M | $101.0M | $83.4M | $90.7M | $89.3M | $79.8M | $77.1M | $85.0M | $81.5M | $79.5M | $80.1M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $83.5M | $80.3M | $68.9M | $53.8M | $59.1M | $58.5M | $52.3M | $51.4M | $48.1M | $45.3M | $46.2M | $43.2M |
| Net income | $55.6M | $40.0M | $38.1M | $32.8M | $36.9M | $34.1M | $43.2M | $28.5M | $35.2M | $30.9M | $32.0M | $29.3M |
| Net margin | 45.8% | 34.8% | 37.7% | 39.4% | 40.7% | 38.2% | 54.2% | 37.0% | 41.5% | 37.9% | 40.3% | 36.6% |
| Diluted EPS | $1.15 | $0.82 | $0.80 | $0.69 | $0.79 | $0.74 | $0.95 | $0.65 | $0.81 | $0.71 | $0.74 | $0.68 |
| EBITDA | $109.1M | $104.0M | $93.4M | $74.1M | $80.3M | $77.9M | $73.9M | $69.2M | $65.5M | $62.8M | $46.2M | $60.7M |
| Operating cash flow | $65.0M | $53.4M | $67.7M | $62.5M | $59.8M | $46.5M | $57.6M | $48.6M | $60.7M | $40.8M | $53.2M | $49.7M |
| Free cash flow | $56.7M | $50.5M | $57.6M | $57.5M | $57.2M | $44.3M | $51.0M | $41.9M | $57.2M | $37.9M | $48.9M | $43.1M |
| Diluted shares | 48.5M | 48.5M | 47.9M | 47.6M | 46.8M | 45.9M | 45.4M | 44.0M | 43.6M | 43.4M | 43.4M | 43.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.4M | $24.9M | $19.6M | $81.6M | $18.6M | $135.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.27B | $1.27B | $1.16B | $1.11B | $1.12B | $1.26B |
| Total assets | $2.96B | $2.89B | $2.80B | $2.69B | $2.70B | $2.78B |
| Total liabilities | $1.37B | $1.36B | $1.26B | $1.19B | $1.20B | $1.34B |
| Shareholders' equity | $1.58B | $1.52B | $1.53B | $1.49B | $1.49B | $1.44B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology